Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shay Shemesh currently holds 1,493,068 shares of Nuvectis Pharma, Inc. (NVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shay Shemesh has been a net buyer of NVCT stock. They have purchased $94.5K and sold $0 worth of shares.
Shay Shemesh's most recent insider trade was on May 10, 2024, when they purchased 1,113 shares at $6.32 per share.
Shay Shemesh serves as Executive at Nuvectis Pharma, Inc. (NVCT). They have executed 21 insider transactions totaling $94.5K over their tenure at the company.
Shay Shemesh holds the position of Executive at Nuvectis Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Shay Shemesh has shown a buying trading pattern, with $94.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Shay Shemesh was on May 12, 2022, when they purchased $18.8K worth of NVCT shares. This transaction involved 1,184 shares at $15.85 per share.
Shay Shemesh currently owns 1,493,068 shares of Nuvectis Pharma, Inc. (NVCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shay Shemesh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shay Shemesh has 21 Form 4 filings on record as an insider at Nuvectis Pharma, Inc..
Set alerts for Shay Shemesh and 40,000+ other insiders.